Case Report of Patients with Acute Respiratory Distress Syndrome Caused by COVID-19: Successfully Treated by Venovenous Extracorporeal Membrane Oxygenation and an Ultra-Protective Ventilation
Coronavirus disease (COVID-19) started in Wuhan (China) at the end of 2019, and then increased rapidly. In patients with severe acute respiratory distress syndrome (ARDS) caused by COVID-19, venovenous extracorporeal membrane oxygenation (VV-ECMO) is considered a rescue therapy that provides adequat...
Main Authors: | Mi Hwa Park, Ah Jin Kim, Man-Jong Lee, Young Sam Kim, Jung Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/56/11/570 |
Similar Items
-
The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study
by: Meng-Yu Wu, et al.
Published: (2017-12-01) -
Effect of prone position in patients with acute respiratory distress syndrome supported by venovenous extracorporeal membrane oxygenation: a retrospective cohort study
by: Ziying Chen, et al.
Published: (2022-06-01) -
Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous extracorporeal membrane oxygenation: a systematic review
by: Wenli Li, et al.
Published: (2024-01-01) -
Conversion from Venovenous to Venoarterial Extracorporeal Membrane Oxygenation in Adults
by: Lars Falk, et al.
Published: (2021-03-01) -
Sodium bicarbonate buffer for weaning from venovenous extracorporeal membrane oxygenation in patients with hypercapnic respiratory failure and acute renal failure
by: Sua Kim, et al.
Published: (2022-01-01)